Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2020

Open Access 01-12-2020 | Hepatocellular Carcinoma | Correction

Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma

Authors: Lei Lv, Yujia Zhao, Qinqin Wei, Ye Zhao, Qiyi Yi

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Excerpt

Following publication of the original article [1], we were notified of a few changes in the author affiliations. The correct affiliations for the authors are listed below: …
Literature
1.
Metadata
Title
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Authors
Lei Lv
Yujia Zhao
Qinqin Wei
Ye Zhao
Qiyi Yi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01575-3

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue

Primary research

Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo

Review

The role of extracellular vesicles in cholangiocarcinoma

Review

Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches

Primary research

Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis

Primary research

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer

Primary research

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits